These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 18175338

  • 1. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
    Paus S, Grünewald A, Klein C, Knapp M, Zimprich A, Janetzky B, Möller JC, Klockgether T, Wüllner U.
    Mov Disord; 2008 Mar 15; 23(4):599-602. PubMed ID: 18175338
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
    Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY, Fook-Cheong SM, Teoh ML, Yih Y, Wong MC, Zhao Y.
    Mov Disord; 2003 May 15; 18(5):593-5. PubMed ID: 12722176
    [Abstract] [Full Text] [Related]

  • 3. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
    Rissling I, Geller F, Bandmann O, Stiasny-Kolster K, Körner Y, Meindorfner C, Krüger HP, Oertel WH, Möller JC.
    Mov Disord; 2004 Nov 15; 19(11):1279-84. PubMed ID: 15390060
    [Abstract] [Full Text] [Related]

  • 4. The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals.
    Cerasa A, Gioia MC, Tarantino P, Labate A, Arabia G, Annesi G, Lanza P, Di Palma G, Blasi V, Quattrone A.
    Genes Brain Behav; 2009 Jun 15; 8(4):459-63. PubMed ID: 19476502
    [Abstract] [Full Text] [Related]

  • 5. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.
    Paus S, Gadow F, Knapp M, Klein C, Klockgether T, Wüllner U.
    Mov Disord; 2009 May 15; 24(7):1080-4. PubMed ID: 19353703
    [Abstract] [Full Text] [Related]

  • 6. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
    Kwak Y, Bohnen NI, Müller ML, Dayalu P, Burke DT, Seidler RD.
    Behav Brain Res; 2013 May 15; 245():128-36. PubMed ID: 23439215
    [Abstract] [Full Text] [Related]

  • 7. DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients.
    Rieck M, Schumacher-Schuh AF, Altmann V, Francisconi CL, Fagundes PT, Monte TL, Callegari-Jacques SM, Rieder CR, Hutz MH.
    Pharmacogenomics; 2012 Nov 15; 13(15):1701-10. PubMed ID: 23171335
    [Abstract] [Full Text] [Related]

  • 8. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.
    Makoff AJ, Graham JM, Arranz MJ, Forsyth J, Li T, Aitchison KJ, Shaikh S, Grünewald RA.
    Pharmacogenetics; 2000 Feb 15; 10(1):43-8. PubMed ID: 10739171
    [Abstract] [Full Text] [Related]

  • 9. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S, Tings T, Helmschmied K, Neubert K, Wuttke W, Paulus W, Trenkwalder C.
    Mov Disord; 2004 Dec 15; 19(12):1511-5. PubMed ID: 15390061
    [Abstract] [Full Text] [Related]

  • 10. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
    Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H.
    Am J Med Genet; 1994 Dec 15; 54(4):361-4. PubMed ID: 7726209
    [Abstract] [Full Text] [Related]

  • 11. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
    Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A.
    Parkinsonism Relat Disord; 2012 May 15; 18(4):397-9. PubMed ID: 22113132
    [Abstract] [Full Text] [Related]

  • 12. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.
    Zappia M, Annesi G, Nicoletti G, Arabia G, Annesi F, Messina D, Pugliese P, Spadafora P, Tarantino P, Carrideo S, Civitelli D, De Marco EV, Cirò-Candiano IC, Gambardella A, Quattrone A.
    Arch Neurol; 2005 Apr 15; 62(4):601-5. PubMed ID: 15824260
    [Abstract] [Full Text] [Related]

  • 13. Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.
    Xu S, Liu J, Yang X, Qian Y, Xiao Q.
    J Neurol Sci; 2017 Jan 15; 372():433-438. PubMed ID: 27817855
    [Abstract] [Full Text] [Related]

  • 14. Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.
    Rieck M, Schumacher-Schuh AF, Altmann V, Callegari-Jacques SM, Rieder CRM, Hutz MH.
    Pharmacogenomics J; 2018 Jan 15; 18(1):196-200. PubMed ID: 27779245
    [Abstract] [Full Text] [Related]

  • 15. Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas.
    Filopanti M, Lania AG, Spada A.
    Expert Opin Drug Metab Toxicol; 2010 Jan 15; 6(1):43-53. PubMed ID: 19929252
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
    Strong JA, Dalvi A, Revilla FJ, Sahay A, Samaha FJ, Welge JA, Gong J, Gartner M, Yue X, Yu L.
    Mov Disord; 2006 May 15; 21(5):654-9. PubMed ID: 16435402
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D4 receptor polymorphism and idiopathic Parkinson's disease.
    Kronenberg MF, Menzel HJ, Ebersbach G, Wenning GK, Luginger E, Gollner M, Ransmayr G, Utermann G, Poewe W, Kronenberg F.
    Eur J Hum Genet; 1999 Apr 15; 7(3):397-400. PubMed ID: 10234518
    [Abstract] [Full Text] [Related]

  • 19. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
    Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A.
    Mov Disord; 2000 Jan 15; 15(1):127-31. PubMed ID: 10634251
    [Abstract] [Full Text] [Related]

  • 20. Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism.
    Paus S, Gadow F, Kaut O, Knapp M, Klein C, Klockgether T, Wüllner U.
    Parkinsonism Relat Disord; 2010 Jul 15; 16(6):381-3. PubMed ID: 20434388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.